SUNNYVALE, Calif. , July 24, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that studies validating the benefits of CyberKnife ® and Radixact ® System software innovations were shared by prominent physicists at the recent 61 st annual meeting of the American Association
SUNNYVALE, Calif. , July 23, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today provided an update on the operational progress of its China joint venture, CNNC Accuray (Tianjin) Medical Technology Co., Ltd (CNNC Accuray). CNNC Accuray has received the Radiation Safety License from the
SUNNYVALE, Calif. , July 19, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2019 ended June 30, 2019 on Thursday, August 15, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m.
First Multi-System Agreement by a Hospital for Both Accuray and RaySearch Products The Swiss Medical Network, Accuray and RaySearch Have Also Partnered to Expand Opportunities for Training Healthcare Professionals on the Latest Technologies SUNNYVALE, Calif.
Hospital is the First in Asia to Procure Synchrony for Radixact, Furthering Its Goal to Use Advanced Medical Technology to Improve Cancer Treatments SUNNYVALE, Calif. , May 1, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with Hong
Only Radiotherapy System with Helical Delivery Capability and Intrafraction Motion Synchronization Functionality, Offering Expanded Versatility and Increased Precision in the Treatment of Simple to Complex Tumors SUNNYVALE, Calif. , April 24, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY)
SUNNYVALE, Calif. , April 23, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2019 ended March 31, 2019 . Fiscal Third Quarter Highlights Gross orders increased 12 percent year over year to $83.6 million Ending backlog
SUNNYVALE, Calif. , April 2, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2019 on Tuesday, April 23, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Data Presented at the 2019 Genitourinary Cancers Symposium Reinforces Benefits of Short Course of Treatment Using Stereotactic Body Radiation Therapy for Low- or Intermediate-Risk Prostate Cancer SUNNYVALE, Calif. , Feb. 22, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today
Joint Venture Uniquely Positioned to Serve World's Largest Growth Market for Radiation Oncology Systems Conference Call Today at 6:00 a.m. PT/ 9:00 a.m. ET SUNNYVALE, Calif. and TIANJIN, China , Jan. 28, 2019 /PRNewswire/ -- Accuray Asia Limited , a subsidiary of Accuray Incorporated (NASDAQ:
